SCHOTT Pharma AG & Co. KGaA (1SXP) — Net Asset Momentum
SCHOTT Pharma AG & Co. KGaA (1SXP) recorded a net asset momentum of 14.5% as of June 2024, with net assets of €792.27 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check SCHOTT Pharma AG & Co. KGaA tangible equity quality to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
SCHOTT Pharma AG & Co. KGaA Net Asset Momentum (2020–2024)
This chart tracks SCHOTT Pharma AG & Co. KGaA's year-over-year net asset growth across 5 annual reporting periods from 2020 to 2024. The most recent momentum reading is +14.5%, with net assets of €792.27 Million EUR as of June 2024. Read 1SXP current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for SCHOTT Pharma AG & Co. KGaA (2020–2024)
The table below shows the complete annual net asset history for SCHOTT Pharma AG & Co. KGaA from 2020 to 2024, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market cap of SCHOTT Pharma AG & Co. KGaA.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €792.27 Million | €1.44 Billion | €650.00 Million | ▲ +14.5% |
| 2023 | €692.18 Million | €1.23 Billion | €539.65 Million | ▼ -2.4% |
| 2022 | €709.04 Million | €1.20 Billion | €487.46 Million | ▲ +69.1% |
| 2021 | €419.42 Million | €739.89 Million | €320.48 Million | ▲ +32.9% |
| 2020 | €315.66 Million | €596.02 Million | €280.36 Million | — |